BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 17115386)

  • 21. Clinical correlates of mitochondrial function in Huntington's disease muscle.
    Turner C; Cooper JM; Schapira AH
    Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juvenile onset Huntington disease resulting from a very large maternal expansion.
    Nahhas FA; Garbern J; Krajewski KM; Roa BB; Feldman GL
    Am J Med Genet A; 2005 Sep; 137A(3):328-31. PubMed ID: 16096998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Huntington's disease: clinical presentation and treatment.
    Novak MJ; Tabrizi SJ
    Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of Chinese patients with Huntington's disease carrying CAG repeats beyond 60 within HTT gene.
    Liu ZJ; Sun YM; Ni W; Dong Y; Shi SS; Wu ZY
    Clin Genet; 2014 Feb; 85(2):189-93. PubMed ID: 23398026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of CCG repeats in Huntingtin gene among HD patients and normal populations in Japan.
    Morovvati S; Nakagawa M; Osame M; Karami A
    Arch Med Res; 2008 Jan; 39(1):131-3. PubMed ID: 18068007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
    Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
    J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.
    Lorincz MT; Zawistowski VA
    Mol Cell Neurosci; 2009 Jan; 40(1):1-13. PubMed ID: 18625318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
    Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
    Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Huntington's disease as caused by 34 CAG repeats.
    Andrich J; Arning L; Wieczorek S; Kraus PH; Gold R; Saft C
    Mov Disord; 2008 Apr; 23(6):879-81. PubMed ID: 18307262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a transgenic model of Huntington's disease in a non-human primate.
    Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW
    Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse models of Huntington's disease.
    Menalled LB; Chesselet MF
    Trends Pharmacol Sci; 2002 Jan; 23(1):32-9. PubMed ID: 11804649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!
    Banoei MM; Houshmand M; Panahi MS; Shariati P; Rostami M; Manshadi MD; Majidizadeh T
    Cell Mol Neurobiol; 2007 Nov; 27(7):867-75. PubMed ID: 17952586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene.
    Kovtun IV; Therneau TM; McMurray CT
    Hum Mol Genet; 2000 Nov; 9(18):2767-75. PubMed ID: 11063736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
    J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.
    Gu X; Richman J; Langfelder P; Wang N; Zhang S; Bañez-Coronel M; Wang HB; Yang L; Ramanathan L; Deng L; Park CS; Choi CR; Cantle JP; Gao F; Gray M; Coppola G; Bates GP; Ranum LPW; Horvath S; Colwell CS; Yang XW
    Neuron; 2022 Apr; 110(7):1173-1192.e7. PubMed ID: 35114102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically confirmed Huntington's disease masquerading as motor neuron disease.
    Kanai K; Kuwabara S; Sawai S; Nakata M; Misawa S; Isose S; Hirano S; Kawaguchi N; Katayama K; Hattori T
    Mov Disord; 2008 Apr; 23(5):748-51. PubMed ID: 18186118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chorea Huntington: a rare case with childhood onset.
    Gencik M; Hammans C; Strehl H; Wagner N; Epplen JT
    Neuropediatrics; 2002 Apr; 33(2):90-2. PubMed ID: 12075490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Huntington's disease: how intermediate are intermediate repeat lengths?
    Squitieri F; Jankovic J
    Mov Disord; 2012 Dec; 27(14):1714-7. PubMed ID: 23008174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.
    Jimenez-Sanchez M; Licitra F; Underwood BR; Rubinsztein DC
    Cold Spring Harb Perspect Med; 2017 Jul; 7(7):. PubMed ID: 27940602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.